688393 安必平
已收盘 10-10 15:00:01
资讯
新帖
简况
每周股票复盘:安必平(688393)临时股东大会审议通过募投项目场地调整议案
证券之星 · 09-13
每周股票复盘:安必平(688393)临时股东大会审议通过募投项目场地调整议案
每周股票复盘:安必平(688393)上半年营收降30.11%
证券之星 · 08-31
每周股票复盘:安必平(688393)上半年营收降30.11%
安必平:8月22日进行路演,中信证券、华鑫证券等多家机构参与
证券之星 · 08-27
安必平:8月22日进行路演,中信证券、华鑫证券等多家机构参与
每周股票复盘:安必平(688393)股东户数减少,上半年营收下滑30.11%
证券之星 · 08-23
每周股票复盘:安必平(688393)股东户数减少,上半年营收下滑30.11%
安必平股价下跌1.53% 半年度营收1.59亿元
金融界 · 08-21
安必平股价下跌1.53% 半年度营收1.59亿元
安必平:上半年亏损1249.85万元
金融界 · 08-21
安必平:上半年亏损1249.85万元
安必平公布半年报 上半年净利减少176.38%
新浪财经-鹰眼工作室 · 08-21
安必平公布半年报 上半年净利减少176.38%
每周股票复盘:安必平(688393)股东南京干靖拟减持不超1.79%股份
证券之星 · 08-16
每周股票复盘:安必平(688393)股东南京干靖拟减持不超1.79%股份
安必平(688393.SH):南京干靖拟减持不超1.79%股份
智通财经 · 08-13
安必平(688393.SH):南京干靖拟减持不超1.79%股份
AI医疗概念盘中拉升,超研股份涨4.40%
市场透视 · 08-11
AI医疗概念盘中拉升,超研股份涨4.40%
医疗器械行业行业研究:脑机接口行业深度:政策+创新双轮驱动,商业化落地进入快车道
国金证券 · 08-10
医疗器械行业行业研究:脑机接口行业深度:政策+创新双轮驱动,商业化落地进入快车道
医疗器械行业盘中拉升,热景生物涨12.83%
市场透视 · 08-06
医疗器械行业盘中拉升,热景生物涨12.83%
AI医疗概念盘中跳水,创业慧康跌2.52%
市场透视 · 08-04
AI医疗概念盘中跳水,创业慧康跌2.52%
AI医疗概念盘中拉升,成都先导涨4.39%
市场透视 · 08-01
AI医疗概念盘中拉升,成都先导涨4.39%
AI医疗概念盘中拉升,达安基因涨1.88%
市场透视 · 07-31
AI医疗概念盘中拉升,达安基因涨1.88%
安必平最新公告:公司5个产品获得欧盟CE认证
证券之星 · 07-29
安必平最新公告:公司5个产品获得欧盟CE认证
AI医疗概念盘中拉升,成都先导涨11.16%
市场透视 · 07-22
AI医疗概念盘中拉升,成都先导涨11.16%
安必平中标2025学科建设耗材项目 券商买入评级彰显成长潜力
自选股中标信息 · 07-17
安必平中标2025学科建设耗材项目 券商买入评级彰显成长潜力
多家跨国医疗巨头奔赴链博会,本土药械供应链再升级
第一财经 · 07-15
多家跨国医疗巨头奔赴链博会,本土药械供应链再升级
安必平涨5.12%创近1个月新高 HPV检测试剂盒获批提振预期
智选洞察 · 07-15
安必平涨5.12%创近1个月新高 HPV检测试剂盒获批提振预期
加载更多
公司概况
公司名称:
广州安必平医药科技股份有限公司
所属行业:
医药制造业
上市日期:
2020-08-20
主营业务:
广州安必平医药科技股份有限公司的主营业务是肿瘤筛查及诊断试剂、自动化设备及辅助诊断人工智能软件等。公司的主要产品是肿瘤筛查及诊断试剂、自动化设备、辅助诊断人工智能软件。公司共拥有三类医疗器械注册证16项,二类医疗器械注册证9项,一类医疗器械备案证579项;共拥有发明专利35项,实用新型专利87项,外观设计专利38项,软件著作权85项。
发行价格:
30.56
{"stockData":{"symbol":"688393","market":"SH","secType":"STK","nameCN":"安必平","latestPrice":26.11,"timestamp":1760079601000,"preClose":26.82,"halted":0,"volume":1535986,"delay":0,"changeRate":-0.0265,"floatShares":93567700,"shares":93567700,"eps":-0.081,"marketStatus":"已收盘","change":-0.71,"latestTime":"10-10 15:00:01","open":26.72,"high":26.88,"low":26.11,"amount":40602500,"amplitude":0.0287,"askPrice":26.14,"askSize":9,"bidPrice":26.11,"bidSize":179,"shortable":0,"etf":0,"ttmEps":-0.081,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1760319000000},"marketStatusCode":5,"adr":0,"adjPreClose":26.82,"symbolType":"stock_kcb","openAndCloseTimeList":[[1760059800000,1760067000000],[1760072400000,1760079600000]],"highLimit":29.5,"lowLimit":24.14,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":93567699,"isCdr":false,"pbRate":1.98,"roa":"--","roe":"--","epsLYR":0.23,"committee":0.392045,"marketValue":2443000000,"turnoverRate":0.0164,"status":1,"afterMarket":{"amount":0,"volume":0,"close":26.11,"buyVolume":0,"sellVolume":491,"time":1760081637768,"indexStatus":"已收盘 10-10 15:30:00","preClose":26.82},"floatMarketCap":2443000000},"requestUrl":"/m/hq/s/688393","defaultTab":"news","newsList":[{"id":"2567136511","title":"每周股票复盘:安必平(688393)临时股东大会审议通过募投项目场地调整议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2567136511","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567136511?lang=zh_cn&edition=full","pubTime":"2025-09-14 04:42","pubTimestamp":1757796135,"startTime":"0","endTime":"0","summary":"截至2025年9月12日收盘,安必平报收于27.8元,较上周的28.09元下跌1.03%。本周,安必平9月12日盘中最高价报28.88元。安必平当前最新总市值26.37亿元,在医疗器械板块市值排名118/126,在两市A股市值排名4767/5153。本周关注点公司公告汇总:安必平2025年第一次临时股东大会审议通过暂时调整部分募集资金投资项目闲置场地用途的议案,同意股数占比99.6738%。信达律师认为,本次股东大会的召集、召开程序、出席人员资格、表决程序及表决结果合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091400001073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688393"],"gpt_icon":0},{"id":"2563369468","title":"每周股票复盘:安必平(688393)上半年营收降30.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563369468","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563369468?lang=zh_cn&edition=full","pubTime":"2025-08-31 10:19","pubTimestamp":1756606750,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘,安必平报收于29.72元,较上周的31.9元下跌6.83%。本周,安必平8月25日盘中最高价报34.2元。本周关注点来自业绩披露要点:2025年上半年公司营业收入1.59亿元,同比下降30.11%。来自机构调研要点:HPV产品线毛利额下降83.00%致利润总额同比降333.51%。公司归属于上市公司股东的净利润下降176.38%,主要原因系公司利润总额下降。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100003061.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393"],"gpt_icon":0},{"id":"2562274349","title":"安必平:8月22日进行路演,中信证券、华鑫证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2562274349","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562274349?lang=zh_cn&edition=full","pubTime":"2025-08-27 19:31","pubTimestamp":1756294303,"startTime":"0","endTime":"0","summary":"证券之星消息,2025年8月27日安必平发布公告称公司于2025年8月22日进行路演,中信证券、华鑫证券、中信建投、申万宏源、晨燕资产、东方财富、义柏资本、彼得明奇私募、天风证券、招商证券、东北证券、国科龙晖、富安达基金、和讯咨询、隆象投资、上海摩旗投资、国元计算机、荣信泰私募、华西证券、国海证券、博真生物、交银施罗德、银河基金管理、湘财证券、高竹基金、圆石投资、上海翀云私募、国源信达参与。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082700044042.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1521","BK1564","BK1147","LU1255011170.USD","LU2148510915.USD","06030","LU0405327494.USD","BK0276","LU0405327148.USD","LU1997244956.HKD","BK0188","BK0012","LU2289578879.USD","LU1655091616.SGD","LU1794554557.SGD","BK0239","LU1997245094.SGD","LU1997245177.USD","LU1720050803.USD","BK0196","LU2495084118.USD","BK1516","161027","LU1328615791.USD","BK0028","688393","600030","LU1064130708.USD","LU1064131003.USD","BK0183"],"gpt_icon":0},{"id":"2561253800","title":"每周股票复盘:安必平(688393)股东户数减少,上半年营收下滑30.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561253800","media":"证券之星","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561253800?lang=zh_cn&edition=full","pubTime":"2025-08-24 05:58","pubTimestamp":1755986291,"startTime":"0","endTime":"0","summary":"截至2025年8月22日收盘,安必平报收于31.9元,较上周的30.22元上涨5.56%。公司公告汇总广州安必平医药科技股份有限公司2025年半年度报告摘要显示,公司总资产为1325045395.80元,较上年度末减少2.77%。营业收入为159397066.02元,较上年同期减少30.11%。广州安必平医药科技股份有限公司发布关于2025年半年度募集资金存放与实际使用情况的专项报告,截至2025年6月30日,累计使用募集资金53776.73万元,尚未使用的募集资金余额12935.19万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082400001046.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688393"],"gpt_icon":0},{"id":"2561948384","title":"安必平股价下跌1.53% 半年度营收1.59亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2561948384","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561948384?lang=zh_cn&edition=full","pubTime":"2025-08-21 23:25","pubTimestamp":1755789957,"startTime":"0","endTime":"0","summary":"截至2025年8月21日收盘,安必平股价报30.31元,较前一交易日下跌0.47元,跌幅1.53%。当日成交量为22761手,成交金额达0.69亿元。安必平主营业务为体外诊断产品的研发、生产和销售。2025年半年度报告显示,公司实现营业收入1.59亿元,同比下降30.11%;归属于上市公司股东的净利润为-1249.85万元。相关议案已获董事会审议通过。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/21232552598284.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688393"],"gpt_icon":0},{"id":"2561676493","title":"安必平:上半年亏损1249.85万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2561676493","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561676493?lang=zh_cn&edition=full","pubTime":"2025-08-21 21:06","pubTimestamp":1755781568,"startTime":"0","endTime":"0","summary":"安必平8月21日晚间披露2025年半年度报告,上半年实现营业收入1.59亿元,同比下降30.11%;归母净利润-1249.85万元,同比由盈转亏;基本每股收益-0.13元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/08/21210652596449.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","688393"],"gpt_icon":0},{"id":"2561846131","title":"安必平公布半年报 上半年净利减少176.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561846131","media":"新浪财经-鹰眼工作室","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561846131?lang=zh_cn&edition=full","pubTime":"2025-08-21 18:50","pubTimestamp":1755773400,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 8月21日消息,安必平发布半年度报告。 公告显示,公司半年度营业收入159,397,066.02元,同比减少30.11%,归属上市公司股东的净利润-12,498,511.13元,同比减少176.38%。 公告显示,十大流通股东中,中国建设银行股份有限公司-长城消费增值混合型证券投资基金、王平为新进流通股东。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:小浪快报","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-08-21/doc-infmtwez5924697.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","688393"],"gpt_icon":0},{"id":"2560257229","title":"每周股票复盘:安必平(688393)股东南京干靖拟减持不超1.79%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2560257229","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560257229?lang=zh_cn&edition=full","pubTime":"2025-08-17 04:22","pubTimestamp":1755375731,"startTime":"0","endTime":"0","summary":"截至2025年8月15日收盘,安必平报收于30.22元,较上周的31.05元下跌2.67%。本周,安必平8月12日盘中最高价报31.89元。因股东资金需求,南京干靖拟通过集中竞价方式及大宗交易方式减持所持有的公司股份不超过1677265股,不超过公司目前总股本的1.79%。南京干靖将严格遵守相关法律法规的要求,并及时履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081700000666.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688393"],"gpt_icon":0},{"id":"2559601820","title":"安必平(688393.SH):南京干靖拟减持不超1.79%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2559601820","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559601820?lang=zh_cn&edition=full","pubTime":"2025-08-13 19:23","pubTimestamp":1755084211,"startTime":"0","endTime":"0","summary":"智通财经APP讯,安必平(688393.SH)发布公告,因股东资金需求,南京干靖拟通过集中竞价方式及大宗交易方式减持所持有的公司股份不超过167.73万股(含本数),不超过公司目前总股本的1.79%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1329185.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688393","BK0239"],"gpt_icon":0},{"id":"2558810633","title":"AI医疗概念盘中拉升,超研股份涨4.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558810633","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558810633?lang=zh_cn&edition=full","pubTime":"2025-08-11 10:01","pubTimestamp":1754877664,"startTime":"0","endTime":"0","summary":"08月11日,AI医疗概念盘中拉升,截至10点01分,AI医疗概念整体指数上涨1.07%,报986.530点。从个股上来看,该概念的成分股中,超研股份涨4.40%,祥生医疗、泓博医药、安必平涨幅居前。从资金上来看,截止发稿,AI医疗概念概念主力净流入为-1.28亿,其中国新健康受到资金热捧,主力净流入255.55万;拉长时间线来看,该板块近20日主力资金净流入-17.99亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811100104a480f1ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811100104a480f1ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159891","BK0239","688393","301602","688358","BK0251"],"gpt_icon":0},{"id":"2558835566","title":"医疗器械行业行业研究:脑机接口行业深度:政策+创新双轮驱动,商业化落地进入快车道","url":"https://stock-news.laohu8.com/highlight/detail?id=2558835566","media":"国金证券","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558835566?lang=zh_cn&edition=full","pubTime":"2025-08-10 12:06","pubTimestamp":1754798792,"startTime":"0","endTime":"0","summary":"投资逻辑国内政策叠加资本双重支持,行业迎来重大发展机遇。近年来国内政策端对脑机接口行业支持力度较高,支持性政策在产品注册、医保支付、行业标准等层面均有体现。1)在产品注册方面,国家药监局将配合相关部门出台基于脑机接口技术的医疗器械产品支持政策,脑机接口相关产品有望通过创新器械绿色通道实现更快注册审批。其中医疗健康领域仍是脑机接口应用最大的细分领域。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081012063594da7295&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081012063594da7295&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688656","600645","688755","688108","688253","688075","688393","688289","688161","688581","603987","688114","688016","688271","688317","688029","688193","688358","688607","688068","600587","688366","688298","688767","688576","688217","605369","688026","688389","688468","688606","688613","603205","688410","688575","688301","603222","603976","688677","560260","688013","688314","688085","600807","688277","603387","688198","603658","688236","688050","603014","688067","688139","688338","159883","600055","688273","600529","688580","688212","688426","688617","688351","603880","688151","603309"],"gpt_icon":0},{"id":"2557534632","title":"医疗器械行业盘中拉升,热景生物涨12.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557534632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557534632?lang=zh_cn&edition=full","pubTime":"2025-08-06 09:37","pubTimestamp":1754444249,"startTime":"0","endTime":"0","summary":"08月06日,医疗器械行业盘中拉升,截至09点37分,医疗器械行业整体指数上涨0.50%,报6789.520点。从个股上来看,该行业的成分股中,热景生物涨12.83%,伟思医疗、安必平、大博医疗涨幅居前。从资金上来看,截止发稿,医疗器械行业主力净流入为-5006.67万,其中热景生物受到资金热捧,主力净流入2628.79万;拉长时间线来看,该板块近20日主力资金净流入-27.30亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806093729a47794a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806093729a47794a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688068","688580","BK0239","688393","BK0251","159883"],"gpt_icon":0},{"id":"2556874576","title":"AI医疗概念盘中跳水,创业慧康跌2.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556874576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556874576?lang=zh_cn&edition=full","pubTime":"2025-08-04 09:46","pubTimestamp":1754271993,"startTime":"0","endTime":"0","summary":"08月04日,AI医疗概念盘中跳水,截至09点46分,AI医疗概念整体指数下跌0.53%,报982.160点。从个股上来看,该概念的成分股中,创业慧康跌2.52%,美年健康、安必平、国新健康跌幅居前。从资金上来看,截止发稿,AI医疗概念概念主力净流入为-1.55亿,其中超研股份受到资金热捧,主力净流入403.95万;拉长时间线来看,该板块近20日主力资金净流入-2.87亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080409463397319469&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080409463397319469&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0405327494.USD","BK0114","BK0146","LU0405327148.USD","159891","688393","BK0231","BK0239","300451"],"gpt_icon":0},{"id":"2556850567","title":"AI医疗概念盘中拉升,成都先导涨4.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556850567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556850567?lang=zh_cn&edition=full","pubTime":"2025-08-01 09:39","pubTimestamp":1754012383,"startTime":"0","endTime":"0","summary":"08月01日,AI医疗概念盘中拉升,截至09点39分,AI医疗概念整体指数上涨0.76%,报1001.870点。从个股上来看,该概念的成分股中,成都先导涨4.39%,美年健康、安必平、超研股份涨幅居前。从资金上来看,截止发稿,AI医疗概念概念主力净流入为9190.84万,其中美年健康受到资金热捧,主力净流入3668.92万;拉长时间线来看,该板块近20日主力资金净流入-5.51亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801093943a6ccaa51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801093943a6ccaa51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159891","688222","688393","BK0216","BK0239"],"gpt_icon":0},{"id":"2555079883","title":"AI医疗概念盘中拉升,达安基因涨1.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555079883","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555079883?lang=zh_cn&edition=full","pubTime":"2025-07-31 09:36","pubTimestamp":1753925817,"startTime":"0","endTime":"0","summary":"07月31日,AI医疗概念盘中拉升,截至09点36分,AI医疗概念整体指数上涨0.60%,报991.090点。从个股上来看,该概念的成分股中,达安基因涨1.88%,药石科技、安必平、迪安诊断涨幅居前。从资金上来看,截止发稿,AI医疗概念概念主力净流入为-676.30万,其中卫宁健康受到资金热捧,主力净流入1261.10万;拉长时间线来看,该板块近20日主力资金净流入-7.14亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507310936579728ec4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507310936579728ec4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["002030","BK0122","688393","159891","BK0159","BK0168","BK0042","BK0046","BK0239","BK0028","BK0188"],"gpt_icon":0},{"id":"2555039507","title":"安必平最新公告:公司5个产品获得欧盟CE认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2555039507","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555039507?lang=zh_cn&edition=full","pubTime":"2025-07-29 17:06","pubTimestamp":1753780016,"startTime":"0","endTime":"0","summary":"安必平(688393.SH)公告称,公司5个产品近期获得欧盟CE认证,包括制片染色一体机、全自动封片机、LBP-4032耗材伴侣、LBP-2390耗材伴侣(妇科)和LBP-2364耗材伴侣(妇科)。这些产品可在欧盟及欧洲经济区(EEA)市场进行销售,并有助于进入其他认可或参考欧盟标准的国际市场。这将进一步拓宽公司相关产品的海外应用场景。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072900028240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["FSXEmain","FESXmain","BK0239","688393"],"gpt_icon":0},{"id":"2553428824","title":"AI医疗概念盘中拉升,成都先导涨11.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553428824","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553428824?lang=zh_cn&edition=full","pubTime":"2025-07-22 09:44","pubTimestamp":1753148687,"startTime":"0","endTime":"0","summary":"07月22日,AI医疗概念盘中拉升,截至09点44分,AI医疗概念整体指数上涨1.06%,报972.310点。从个股上来看,该概念的成分股中,成都先导涨11.16%,药石科技、泓博医药、安必平涨幅居前。从资金上来看,截止发稿,AI医疗概念概念主力净流入为1744.02万,其中成都先导受到资金热捧,主力净流入4499.06万;拉长时间线来看,该板块近20日主力资金净流入-4.37亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722094447a6b96e76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722094447a6b96e76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688222","159891","BK0216","BK0239","688393"],"gpt_icon":0},{"id":"2552484420","title":"安必平中标2025学科建设耗材项目 券商买入评级彰显成长潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2552484420","media":"自选股中标信息","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552484420?lang=zh_cn&edition=full","pubTime":"2025-07-17 19:05","pubTimestamp":1752750337,"startTime":"0","endTime":"0","summary":"2025年07月17日,据天眼查数据,RbGeneProtein抗体试剂成交结果公示显示,中标方为安必平,招标方为连云港市第一人民医院。近半年内,安必平获得1家券商积极评价:华鑫证券给予\"买入\"评级。安必平主营业务涵盖自产产品,外购产品,服务收入,其他收入之和。截至发稿,安必平股价报30.7元,上涨1.86%,成交额至9849.98万元。中标数据由天眼查提供,由程序或算法识别中标信息页面生成,可能与实际存在差异,不作为决策依据。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717190544a450f6d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717190544a450f6d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688393"],"gpt_icon":0},{"id":"2551662190","title":"多家跨国医疗巨头奔赴链博会,本土药械供应链再升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2551662190","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551662190?lang=zh_cn&edition=full","pubTime":"2025-07-16 00:15","pubTimestamp":1752596100,"startTime":"0","endTime":"0","summary":"第一财经记者获悉,即将于7月16日开幕的第三届中国国际供应链促进博览会,包括美敦力、阿斯利康、GE医疗等跨国医疗巨头确认参展。美敦力方面介绍,今年是该公司首次参加链博会,并将展示一款全新的由美敦力中国研发中心和本土临床专家合作的起搏心脏导管研发成果。在本届链博会上,阿斯利康国际市场供应链管理高级执行总裁Steven Rota也将发表主旨演讲。阿斯利康已连续第三年参加链博会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716062402a44d2312&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716062402a44d2312&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603658","688607","688581","603014","688271","688273","688755","603880","688161","688338","BK0239","688399","688656","688050","688139","603222","688217","688212","688767","688626","600645","688410","688351","688575","688114","688193","688606","688389","688253","688016","600055","603387","688468","688108","605369","688580","688366","603976","688236","688085","603205","688301","688314","688317","688677","688029","688393","688617","688151","600807","600587","688358","688426","688013","688613","688067","688075","688026","603301","688289","688298","603309","688576","159891","688068","603987","600529","688198"],"gpt_icon":0},{"id":"2551243159","title":"安必平涨5.12%创近1个月新高 HPV检测试剂盒获批提振预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2551243159","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551243159?lang=zh_cn&edition=full","pubTime":"2025-07-15 14:20","pubTimestamp":1752560420,"startTime":"0","endTime":"0","summary":"安必平股价今日大幅上涨,截至14点19分,最新价报30.59元,上涨5.12%,创近1个月新高,并成功突破30元整数关口。资金博弈与政策催化共振安必平近日股价波动受多重短期因素影响。7月9日公司公告取得HPV检测试剂盒注册证,新产品获批引发市场预期切换,当日量比冲高至2.46显示交易活跃度骤增。2024年报显示自产产品收入占比近80%,核心产品HPV检测试剂盒获批后有望打开新增长空间。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715142023a44b8e8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715142023a44b8e8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688393","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1760144139188,"stockEarnings":[{"period":"1week","weight":-0.0214},{"period":"1month","weight":-0.0512},{"period":"3month","weight":-0.1185},{"period":"6month","weight":-0.1657},{"period":"1year","weight":0.4567},{"period":"ytd","weight":0.514}],"compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":0.0222},{"period":"3month","weight":0.1102},{"period":"6month","weight":0.2034},{"period":"1year","weight":0.1802},{"period":"ytd","weight":0.1627}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广州安必平医药科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"9221人(较上一季度减少10.55%)","perCapita":"10147股","listingDate":"2020-08-20","address":"广东省广州市黄埔区科学城风信路科信街2号","registeredCapital":"9356万元","survey":" 广州安必平医药科技股份有限公司的主营业务是肿瘤筛查及诊断试剂、自动化设备及辅助诊断人工智能软件等。公司的主要产品是肿瘤筛查及诊断试剂、自动化设备、辅助诊断人工智能软件。公司共拥有三类医疗器械注册证16项,二类医疗器械注册证9项,一类医疗器械备案证579项;共拥有发明专利35项,实用新型专利87项,外观设计专利38项,软件著作权85项。","listedPrice":30.56},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安必平(688393)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安必平(688393)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安必平,688393,安必平股票,安必平股票老虎,安必平股票老虎国际,安必平行情,安必平股票行情,安必平股价,安必平股市,安必平股票价格,安必平股票交易,安必平股票购买,安必平股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安必平(688393)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安必平(688393)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}